O
ONWARD Medical
Neurotechnology enabling recovery after spinal cord injury
About ONWARD Medical
ONWARD is a pioneering startup that operates in the medical technology sector, specifically focusing on spinal cord injury therapies. The company is comprised of a multidisciplinary team of scientists, engineers, and physicians, all united by a common goal: to develop innovative therapies that can significantly improve the lives of people living with spinal cord injuries.
Read full description
ONWARD's flagship product is the ARC Therapy, a groundbreaking technology that uses targeted, programmed stimulation of the spinal cord to restore movement in individuals with spinal cord injuries. This investigational device, which is not yet available for commercial use, has shown potential benefits beyond restoring movement, including improved bladder control, sexual function, and blood pressure regulation.
The company's business model is based on the development and eventual commercialization of its proprietary ARC Therapy. It generates revenue through the licensing of its intellectual property, developed in partnership with leading global neuroscience research institutions such as the Swiss Federal Institute of Technology, Lausanne University Hospital, the University of Louisville, and Caltech.
ONWARD's target market includes individuals with spinal cord injuries, as well as healthcare providers and institutions that treat these patients. The company's long-term financial prospects are promising, given the significant unmet need for effective therapies in this area and the potential for its technology to revolutionize the treatment of spinal cord injuries.
At a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Eindhoven, Netherlands
- Listing
- IPO 2021
- Employees
- 205
- Open positions
- 5
- Dealroom signal
- 84.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Rehabilitation, Developer Tools, Biotechnology, Neurology, Neuromodulation and Neurostimulation, Spinout
- Technology
- Hardware, Deep Tech, Connected Device
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| PRIVATE PLACEMENT NON VC✓Other financing | Apr 2026 | $45M | — | EQT Life Sciences | ↗ |
| PRIVATE PLACEMENT NON VC✓Other financing | Oct 2025 | $58M | — | Ottobock | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for ONWARD Medical is 25K monthly website visits, up 19% over the last three months. ONWARD Medical's team grew 6.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Fondation FIT
MassChallenge
European Commission
Reeve Foundation
Series A7 investors entered at this stage
Inkef
EQT Life Sciences
Wellington Partners
Gimv
Verve Ventures
Invest-NL- OIOlympic Investments
Series B and later2 investors entered at this stage
Netherlands Enterprise Agency (RVO)
Runway Growth Capital
Other known investors6 additional known investors
Ottobock
EPFL Swiss Federal Polytechnic School of Lausanne
b2venture
European Innovation Council
Venture Kick
VentureLab
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ONWARD Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ONWARD Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.